Körber Pharma

Hamburg, Germany Founded: 2004 • Age: 22 yrs
Software development services are provided for the pharmaceutical industry.

About Körber Pharma

Körber Pharma is a Healthcare company based in Hamburg (Germany) founded in 2004. Software development services are provided for the pharmaceutical industry. The company has 107 employees. Its chief executive, as recorded, is Kerry Fillmore. Its website koerber-pharma.com draws about 31 thousand monthly visits. Its Indian entity Koerber Pharma Private Limited reported revenue of ₹70.70 Cr. Its focus areas include Biopharma Outsourcing and Software Development Services.

Company details

Körber Pharma was established in 2004 in Hamburg, Germany, as a provider of software development services tailored to the pharmaceutical sector. Operations are centered on delivering customized software solutions to support industry processes, including compliance and efficiency tools. The company is led by CEO Kerry Fillmore, with its online presence maintained through the domain koerber-pharma.com. Focus remains on serving pharmaceutical clients across Europe and beyond.

  • Headquarters Hamburg, Germany
  • Employees 107
  • Sectors
    Healthcare
  • Website category Business and Consumer Services · Business Services
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website koerber-pharma.com
  • Social LinkedIn Facebook
  • Legal Name Koerber Pharma Private Limited
  • Date of Incorporation 26 Mar, 2018
  • Jurisdiction Navi Mumbai, Maharashtra, India
Key Metrics
  • Indian entity revenue
    ₹70.70 Cr

    FY 2025 · +12% YoY

  • Indian entity net profit
    ₹10.06 Cr

    FY 2025 · 14% margin

  • Indian entity EBITDA
    ₹15.86 Cr

    FY 2025 · 22% margin

  • Investors
  • Employee Count
    107

Funding Insights of Körber Pharma

  • Total Rounds 1
  • Investors Count 1

All 1 funding rounds of Körber Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2023Grant––
Valuation history

1 investors in total: 1 institutional.

Investors in Körber Pharma

Körber Pharma has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Portál veřejné správy.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
A digital platform for public administration services in Czech Republic.
gov.czCzech Republic
Premium access

Investor details for Körber Pharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Koerber Pharma Private Limited (Körber Pharma)

Koerber Pharma Private Limited is the primary company behind Körber Pharma. The board of Koerber Pharma Private Limited currently have 2 directors; the longest-serving is Rajesh Chandrashekhar Vedak, appointed in 2019. 10 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Rajesh Chandrashekhar Vedak
DIN 08557253
Managing Director10 Sep 20197 yrs 1 moKoerber Pharma Private Limited
Oliver Stephan Werner Weber
DIN 11048802
Additional Director21 Apr 20251 yr 6 moKoerber Pharma Private Limited

People of Körber Pharma

1 people are tracked at Körber Pharma (1 in leadership); the tracked headcount is 107.

NameRoleGroup
Kerry Fillmore
CEOLeadership
Premium access

Complete people profiles for Körber Pharma

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Körber Pharma

Figures of Koerber Pharma Private Limited, the primary company behind Körber Pharma, for FY 2025. Revenue was ₹70.70 Cr (+12% year on year). Net profit was ₹10.06 Cr (14% margin). EBITDA was ₹15.86 Cr (22% margin). Revenue has grown at a compounded annual rate of +27% over three years and +57% over five years.

  • ₹70.70 CrRevenue · FY 2025 · +12% YoY
  • ₹10.06 CrNet profit · 14% margin
  • ₹15.86 CrEBITDA · 22% margin
  • ₹1.61 CrPaid-up capital
  • 107Employees (provident fund records)
  • +27%Revenue CAGR, 3 years
  • +57%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Koerber Pharma Private Limited are on its company page.

Premium access

Detailed financial statements for Körber Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Körber Pharma

2 dated milestones of Körber Pharma across 19 years, from founding to its latest funding, stage changes and deals.

  1. Founded Körber Pharma is founded.
  2. Funding First funding round.

Web traffic of Körber Pharma

The website of Körber Pharma (koerber-pharma.com) receives about 31K visits a month and ranks #985,189 among all websites worldwide, #8,043 in Business Services.

  • Monthly visits
    31K

    ▲ 2.6% vs previous month

  • Unique visitors
    12.6K

    per month

  • Global rank
    #985,189

    among all websites

  • Category rank
    #8,043

    Business and Consumer Services · Business Services

Similar websites

Websites whose visitors overlap most with Körber Pharma. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
metabrandcorp.com
100%
#1,584,612View details
koerber-supplychain.com
100%
21.5K#1,027,968View details
llumin.com
91%
#1,362,902View details
getgenea.com
91%
32.4K#559,532View details
spottersecurity.com
spottersecurity.com
91%
#2,118,772–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 15 similar websites and full traffic analytics for Körber Pharma

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 15 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Körber Pharma

Premium access

Complete news archive for Körber Pharma

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Körber Pharma

Körber Pharma was founded in 2004 and raised its 1st funding round 19 years after it was founded.

Körber Pharma is headquartered in Hamburg, Germany. It is registered at Hamburg, Hamburg, Germany.

Kerry Fillmore is the CEO of Körber Pharma, as recorded in our data.

Körber Pharma has 107 employees.

The primary company behind Körber Pharma, Koerber Pharma Private Limited, reported revenue of ₹70.70 Cr for FY 2025, up 12% year on year.

Körber Pharma was established in 2004 in Hamburg, Germany, as a provider of software development services tailored to the pharmaceutical sector. Operations are centered on delivering customized software solutions to support industry processes, including compliance and efficiency tools. The company is led by CEO Kerry Fillmore, with its online presence maintained through the domain koerber-pharma.com. Focus remains on serving pharmaceutical clients across Europe and beyond.

Körber Pharma has 1 investor. Key investors include Portál veřejné správy.

Körber Pharma operates through Koerber Pharma Private Limited.

The legal entities of Körber Pharma currently have 2 directors, including Rajesh Chandrashekhar Vedak, Oliver Stephan Werner Weber.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available